The Evolution of Nephrectomy and Patient Characteristics in Metastatic Renal Cell Carcinoma Patients Enrolled Into First-Line Tyrosine Kinase Inhibitors Clinical Trials-Reference-Cited by-同舟云学术

The Evolution of Nephrectomy and Patient Characteristics in Metastatic Renal Cell Carcinoma Patients Enrolled Into First-Line Tyrosine Kinase Inhibitors Clinical Trials

Published:2016-10 Issue:5 Volume:14 Page:415-419
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Sella Avishay,Wang Kongming,Sella Tal

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference52 articles.

1. Radical nephrectomy plus interferon alfa- based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal cell cancer;Flanigan;N Engl J Med,2001

3. Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma;Crispen;Curr Urol Rep,2012

4. The impact of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy;Choueiri;J Urol,2011

5. Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy;Barbastefano;BJU Int,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Care and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma—Results From a Tertiary Cancer Center in India;Clinical Genitourinary Cancer;2017-06